Production of biological substances for medicine using genetically engineered yeast cells shows new promising results in basic research from an international team of researchers. In 2022, the researchers attracted international attention by programming the longest-ever biosynthetic pathway—or 'assembly line'—into a microbial cell factory and designing it to produce biological substances for cancer drugs.
